We are live on ! Find out more
GKIM

GW&K Investment Management Portfolio holdings

AUM $11.3B
1-Year Est. Return 31.98%
This Fund
S&P 500
This Quarter Est. Return
+6.43%
1 Year Est. Return
+31.98%
3 Year Est. Return
+79.76%
5 Year Est. Return
+101.81%
10 Year Est. Return
+512.72%
AUM
$6.11B
AUM Growth
+$186M
Cap. Flow
-$115M
Cap. Flow %
-1.89%
Top 10 Hldgs %
13.08%
Holding
303
New
11
Increased
95
Reduced
181
Closed
15

Sector Composition

Rank Sector Weight
1 Industrials 16.06%
2 Technology 16%
3 Healthcare 13.61%
4 Financials 13.09%
5 Consumer Discretionary 11.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PACW
51
DELISTED
PacWest Bancorp
PACW
$35M 0.57%
707,788
-23,532
-3% -$1.23M
WMGI
52
DELISTED
Wright Medical Group Inc
WMGI
$34.9M 0.57%
1,344,875
-14,101
-1% -$322K
TYL icon
53
Tyler Technologies
TYL
$13B
$34.8M 0.57%
156,893
-213,475
-58% -$48M
SBNY
54
DELISTED
Signature Bank
SBNY
$34.7M 0.57%
271,521
-4,729
-2% -$620K
PAYX icon
55
Paychex
PAYX
$43.1B
$33.8M 0.55%
494,745
-15,094
-3% -$974K
PPBI
56
DELISTED
Pacific Premier Bancorp
PPBI
$33.7M 0.55%
884,224
+439,436
+99% +$17.9M
WSO icon
57
Watsco Inc
WSO
$13.5B
$33.7M 0.55%
189,062
-5,131
-3% -$933K
WST icon
58
West Pharmaceutical
WST
$24.8B
$33.7M 0.55%
338,966
-5,361
-2% -$493K
HLIO icon
59
Helios Technologies
HLIO
$2.69B
$33.7M 0.55%
698,362
-151
-0% -$7.63K
STE icon
60
Steris
STE
$23.3B
$33.1M 0.54%
315,126
-4,929
-2% -$496K
ENB icon
61
Enbridge
ENB
$112B
$32.2M 0.53%
903,171
-26,942
-3% -$853K
AMRX icon
62
Amneal Pharmaceuticals
AMRX
$5.71B
$32.1M 0.53%
+1,956,906
New +$34.3M
SF
63
Stifel
SF
$12.7B
$32.1M 0.53%
1,382,774
-13,234
-0.9% -$344K
BP icon
64
BP
BP
$110B
$31.9M 0.52%
742,915
-33,555
-4% -$1.41M
PM icon
65
Philip Morris
PM
$290B
$31.9M 0.52%
394,620
+47,720
+14% +$4.05M
CONE
66
DELISTED
CyrusOne Inc Common Stock
CONE
$31.8M 0.52%
544,082
+57,639
+12% +$3.12M
QTS
67
DELISTED
QTS REALTY TRUST, INC.
QTS
$31.6M 0.52%
800,609
-3,741
-0.5% -$138K
CMD
68
DELISTED
Cantel Medical Corporation
CMD
$31.5M 0.52%
320,240
-3,032
-0.9% -$339K
NWE icon
69
NorthWestern Energy
NWE
$4.38B
$31.5M 0.52%
550,109
-4,712
-0.8% -$256K
TTC icon
70
Toro Company
TTC
$9.4B
$31.5M 0.52%
522,395
-7,841
-1% -$473K
PSMT icon
71
Pricesmart
PSMT
$5.21B
$31.4M 0.51%
346,553
-5,067
-1% -$441K
WAB icon
72
Wabtec
WAB
$49.7B
$31.4M 0.51%
318,065
-4,968
-2% -$462K
CATY icon
73
Cathay General Bancorp
CATY
$4.23B
$30.8M 0.5%
759,901
-262,742
-26% -$10.9M
ACC
74
DELISTED
American Campus Communities, Inc.
ACC
$30.7M 0.5%
716,367
-11,004
-2% -$440K
PX
75
DELISTED
Praxair Inc
PX
$30.6M 0.5%
193,326
-5,866
-3% -$906K

Similar funds

GW&K Investment Management's Q2 2018 Portfolio in Review

As of Q2 2018, GW&K Investment Management held 303 positions worth $6.11B, up 3.1% from $5.92B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

GW&K Investment Management's Q2 2018 filing shows 11 new, 95 increased, 181 reduced and 15 closed positions. Its largest new stake was Amneal Pharmaceuticals: 1,956,906 shares worth $32.1M. The largest sale was Tyler Technologies, an estimated $48M.

By sector, the portfolio is most concentrated in Industrials at 16% of assets, up from 15% a quarter earlier, followed by Technology and Healthcare.

  • GW&K Investment Management's largest Q2 2018 buy was Amneal Pharmaceuticals: 1,956,906 shares worth $32.1M.
  • GW&K Investment Management added most to Pacific Premier Bancorp in Q2 2018, an estimated $17.9M increase.
  • GW&K Investment Management's biggest Q2 2018 reduction was Tyler Technologies, cutting an estimated $48M.
  • GW&K Investment Management fully exited Impax Laboratories, Inc. in Q2 2018, selling an estimated $38.5M.
  • GW&K Investment Management's ten largest holdings make up 13% of its $6.11B portfolio in Q2 2018.
  • GW&K Investment Management opened 11 new positions and closed 15 in Q2 2018.
  • GW&K Investment Management's portfolio value rose 3.1% quarter-over-quarter to $6.11B.

Based on GW&K Investment Management's 13F filing for Q2 2018, filed 7 Aug 2018.